Poland· PL-100452843

TamisPras DUO

A tamsulosin und solifenacin product containing solifenacini succinas + tamsulosini hydrochloridum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.

ATC G04CA53

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTamisPras DUOATCG04CA53REGISTER NO.PL-100452843PACKS LISTED23CHECKEDSeptember 27, 2026

Where it is registered

Tamsulosin und solifenacin is registered in 9 of 19 countries.

Countries holding a registration under ATC G04CA53 (tamsulosin und solifenacin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Tamsulosin und solifenacin · ATC G04CA53

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Solifenacini succinas + Tamsulosini hydrochloridum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
G04CA53
ATC class
Tamsulosin und Solifenacin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 23

1 priced
  • gtin
    05909991519230
    30 szt.
    PLN 30.41
  • gtin
    05909991519193
  • gtin
    05909991519209
  • gtin
    05909991519216
  • gtin
    05909991519223
  • gtin
    05909991519247
  • gtin
    05909991519070
  • gtin
    05909991519087
  • gtin
    05909991519094
  • gtin
    05909991519100
  • gtin
    05909991519117
  • gtin
    05909991519124
  • gtin
    05909991519131
  • gtin
    05909991519148
  • gtin
    05909991519155
  • gtin
    05909991519162
  • gtin
    05909991519179
  • gtin
    05909991519186
  • gtin
    05909991519254
  • gtin
    05909991519261
  • gtin
    05909991519278
  • gtin
    05909991519285
  • gtin
    05909991579746

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tamsulosin und solifenacin in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tamsulosin und solifenacin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Solicomp, Solifenacin/Tamsulosin Stada
  • Belgium · Solifenacine / Tamsulosine Eurogenerics, Solifenacine/Tamsulosine
  • Bulgaria · Везира, Везомни
  • Cyprus · Nefilin
  • Czechia · Beplasot, Jomil
  • Germany · Solifenacin/Tamsulosin Heumann, Solifenacin/Tamsulosin Ratiopharm
  • Denmark · Solifenacin/Tamsulosin Adalvo, Solifenacin/Tamsulosin Newbury
  • Estonia · Solitombo
  • Spain · Blobax, Daital
  • Finland · Solifenacin/Tamsulosin Stada, Urizia
  • France · Vecalmys
  • United Kingdom (Northern Ireland) · Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science, Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science Limited
  • Greece · Desoltam, Nefilin
  • Croatia · Beplasot, Semquest
  • Hungary · Mingerlan, Örgunderin
  • Ireland · Solifenacin Succinate/Tamsulosin, Solifenacin Succinate/Tamsulosin Hydrochloride Clonmel
  • Iceland · Soltamcin
  • Italy · Luracin, Solifenacina E Tamsulosin Mylan
  • Lithuania · Solitombo
  • Luxembourg · Solifenacine/Tamsulosine, Solifenacine/Tamsulosine Eurogenerics
  • Malta · Jomil
  • Netherlands · Jomil, Mingerlan
  • Norway · Solifenacin/Tamsulosin Newbury, Solifenacin/Tamsulosin Stada
  • Portugal · Blatan, Solifenacina + Tansulosina Generis
  • Romania · Mingerlan, Solifenacin/Tamsulosin Gemax Pharma
  • Sweden · Urizia
  • Slovenia · Semquest, Solifenacin/Tamsulozin Belupo
  • Slovakia · Jomil, Solifenacín/Tamsulozín Belupo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/63790c58-b87e-48e1-90e8-65d65c9c2ebc
GET /v1/drugs/63790c58-b87e-48e1-90e8-65d65c9c2ebc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o zmodyfikowanym uwalnianiu",
  "source": "urpl",
  "strength": "6 mg + 0,4 mg",
  "packaging": "05909991519070 ¦ Rp ¦ 150904\n10 tabl. w blistrze\n05909991519087 ¦ Rp ¦ 150905\n30 tabl. w blistrze\n05909991519094 ¦ Rp ¦ 150906\n14 tabl. w blistrze\n05909991519100 ¦ Rp ¦ 150907\n90 tabl. w blistrze\n05909991519117 ¦ Rp ¦ 150908\n28 tabl. w blistrze\n05909991519124 ¦ Rp ¦ 150909\n60 tabl. w blistrze\n05909991519131 ¦ Rp ¦ 150910\n200 tabl. w blistrze\n05909991519148 ¦ Rp ¦ 150911\n50 tabl. w blistrze\n05909991519155 ¦ Rp ¦ 150912\n20 tabl. w blistrze\n05909991519162 ¦ Rp ¦ 150913\n56 tabl. w blistrze\n05909991519179 ¦ Rp ¦ 150914\n100 tabl. w blistrze\n05909991519186 ¦ Rp ¦ 150915\n10 tabl. w blistrze perforowanym\n05909991519193 ¦ Rp ¦ 150916\n50 tabl. w blistrze perforowanym\n05909991519209 ¦ Rp ¦ 150917\n14 tabl. w blistrze perforowanym\n05909991519216 ¦ Rp ¦ 150918\n28 tabl. w blistrze perforowanym\n05909991519223 ¦ Rp ¦ 150919\n20 tabl. w blistrze perforowanym\n05909991519230 ¦ Rp ¦ 150920\n30 tabl. w blistrze perforowanym\n05909991519247 ¦ Rp ¦ 150921\n100 tabl. w blistrze perforowanym\n05909991519254 ¦ Rp ¦ 150922\n200 tabl. w blistrze perforowanym\n05909991519261 ¦ Rp ¦ 150923\n90 tabl. w blistrze perforowanym\n05909991519278 ¦ Rp ¦ 150924\n60 tabl. w blistrze perforowanym\n05909991519285 ¦ Rp ¦ 150925\n56 tabl. w blistrze perforowanym\n05909991579746 ¦ Rp ¦ 162760\n200 tabl. w butelce",
  "substance": "Solifenacini succinas 6 mg + Tamsulosini hydrochloridum 0.4 mg",
  "common_name": "Solifenacini succinas + Tamsulosini hydrochloridum",
  "pl_product_id": "100452843",
  "pozwolenie_nr": "27958",
  "auth_procedure": "DCP",
  "authorisation_validity": "2028-08-11"
}

See everything about tamsulosin und solifenacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.